Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
4(36%)
Results Posted
0%(0 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_3
2
18%
Ph not_applicable
3
27%
Ph phase_2
3
27%

Phase Distribution

0

Early Stage

3

Mid Stage

2

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
3(37.5%)
Phase 3Large-scale testing
2(25.0%)
N/ANon-phased studies
3(37.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

4

trials recruiting

Total Trials

11

all time

Status Distribution
Active(4)
Completed(3)
Terminated(2)
Other(2)

Detailed Status

Completed3
Recruiting3
Suspended1
Terminated1
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
4
Success Rate
75.0%
Most Advanced
Phase 3

Trials by Phase

Phase 23 (37.5%)
Phase 32 (25.0%)
N/A3 (37.5%)

Trials by Status

suspended19%
terminated19%
withdrawn19%
completed327%
recruiting327%
unknown19%
active_not_recruiting19%

Recent Activity

4 active trials
Showing 5 of 11
recruitingphase_2

Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

NCT06265285
recruitingphase_3

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

NCT07200830
suspendedphase_2

Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma

NCT06179888
active_not_recruitingnot_applicable

Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events

NCT05038254
recruitingnot_applicable

Remote Monitoring With Health-Coaching to Improve Quality of Life in Older Patients With Multiple Myeloma

NCT06145581
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT06265285Phase 2

Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

Recruiting
NCT07200830Phase 3

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

Recruiting
NCT06179888Phase 2

Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma

Suspended
NCT05038254Not Applicable

Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events

Active Not Recruiting
NCT06145581Not Applicable

Remote Monitoring With Health-Coaching to Improve Quality of Life in Older Patients With Multiple Myeloma

Recruiting
NCT04501913

Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes

Completed
NCT05018208

Remote Monitoring in Cancer Care: A Platform Study

Completed
NCT03834571Phase 2

Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women

Withdrawn
NCT03895918Not Applicable

Parenting Skills Intervention in Improving Medication Adherence in Pediatric Cancer Patients

Completed
NCT03967119

Assessments of Dynamic Variables of Fluid Responsiveness to Predict Desufflation-induced Hypotension in Urologic Patients Undergoing Laparoscopic Surgery

Unknown
NCT00290082Phase 3

Randomized Double-blind Trial of Midazolam and Loxapine in Agitated Patients

Terminated

All 11 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
11